Zoetis.co.uk uses cookies to improve your experience when browsing our website. By continuing to use this site, you are agreeing to their use. To find out more, view our cookie policy.

United Kingdom
Apoquel Logo

APOQUEL® – the first-in-class JAK inhibitor that breaks the cycle.

An inhibitory molecule specifically designed to target the JAK/STAT pathway, APOQUEL® breaks the cycle of itch and inflammation.

 

understanding the inflammatory and pruritic processes

Proinflammatory, pruritogenic and allergic cytokines play a key role in skin inflammation and in the neurological pathway that triggers pruritus in allergic skin diseases 

 

a unique mode of action

mode of action

Cytokines implicated in allergic skin diseases bind to specific cell receptors and signal through the Janus Kinase (JAK) pathway, leading to a cascade of intracellular events that induce inflammation and pruritus.7

 

APOQUEL® targets the JAK/STAT downstream signalling pathway within the cell inhibiting the activity of proinflammatory, pruritic and allergic cytokines.